Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2016-05-04 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
独立董事对第三届董事会第六次会议相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion from independent directors regarding matters discussed at the company's third board of directors' sixth meeting. It references compliance with regulatory guidelines and company rules, and provides an independent opinion on a guarantee provided by a wholly-owned subsidiary. The document is short (635 characters) and does not contain financial statements or detailed financial data. It is not a full report but rather a formal opinion related to board meeting matters. This fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2016-05-04 Chinese
关于全资子公司为公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 福安药业（集团）股份有限公司 regarding a guarantee provided by its wholly-owned subsidiaries for a bank loan related to a major asset restructuring. It includes details about the guarantee, involved parties, financial data of the guaranteed entity, and approvals by the board and independent directors. The document is relatively short (2360 characters) and focuses on a specific financing guarantee event rather than comprehensive financial statements or full financial performance. It does not contain quarterly or annual financial reports, audit opinions, or earnings highlights. The content aligns with an update on financing activities, specifically a guarantee related to a loan for a capital restructuring. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2016-05-04 Chinese
第三届监事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of the company 福安药业 regarding approval of a guarantee provided by a wholly-owned subsidiary. It includes details about the meeting date, attendance, voting results, and compliance with company law and articles of association. The content is a formal announcement of a board/committee decision rather than a full report or financial statement. It does not contain financial data, earnings, or regulatory certifications. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2016-05-04 Chinese
关于控股股东部分股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder. It details the number of shares pledged, the pledgee, and the proportion of shares involved. There is no financial report, earnings data, or management discussion. The content fits the category of a capital or financing update, specifically about share pledging, which is a financing activity affecting the company's capital structure. The document length is short and it is not an announcement of a report publication but a direct disclosure of a financing event.
2016-05-04 Chinese
第三届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by the company 福安药业（集团）股份有限公司. It details the date of the meeting, attendance, voting results, and the approval of a specific agenda item regarding a guarantee provided by a wholly-owned subsidiary. There is no detailed financial data, no comprehensive report, nor is it a transcript or presentation. The document is an official announcement of board decisions, which fits the category of Board/Management Information (MANG). The document length is short and focused on board resolutions, not a full report or regulatory filing. Therefore, the classification is MANG with high confidence.
2016-05-04 Chinese
发行股份及支付现金购买资产并募集配套资金暨关联交易报告书（修订稿）摘要
Capital/Financing Update Classification · 95% confidence The document is a detailed report titled "发行股份及支付现金购买资产并募集配套资金暨关联交易报告书（修订稿）" which translates to "Report on Issuance of Shares and Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Party Transactions (Revised)". It includes extensive information about a major asset acquisition, issuance of shares, cash payments, fundraising, related party transactions, pricing, lock-up periods, performance commitments, and regulatory compliance references such as the China Securities Regulatory Commission (CSRC) and Shenzhen Stock Exchange rules. The document contains detailed financial data, transaction terms, shareholder structure changes, and legal and regulatory references. This is a comprehensive report on a significant capital and asset transaction involving issuance of shares and cash payment to purchase assets, along with fundraising activities. It is not a simple announcement or a brief summary but a full report with substantive financial and transactional details. Therefore, the document fits the category of Capital/Financing Update (CAP) as it provides updates on company fundraising, financing activities, and capital structure changes related to a major asset acquisition and share issuance.
2016-04-28 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.